Australia markets open in 9 hours 32 minutes

Sorrento Therapeutics, Inc. (SRNE)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
1.9250-0.0650 (-3.27%)
As of 10:28AM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
57,034
52,904
39,986
31,432
21,193
Cost of revenue
15,403
13,031
9,940
12,237
7,060
Gross profit
41,631
39,873
30,046
19,195
14,133
Operating expenses
Research development
227,066
206,922
111,340
106,879
76,963
Selling general and administrative
197,789
196,856
116,179
103,557
63,638
Total operating expenses
428,994
407,918
231,572
214,377
143,610
Operating income or loss
-387,363
-368,045
-201,526
-195,182
-129,477
Interest expense
11,107
10,224
20,181
36,139
57,631
Total other income/expenses net
-105,635
-84,259
-88,897
-129,346
-27,594
Income before tax
-504,105
-462,528
-310,580
-359,576
-213,781
Income tax expense
-31,847
-33,516
-2,014
-473
-6,274
Income from continuing operations
-472,096
-429,138
-314,410
-363,012
-212,526
Net income
-471,650
-428,325
-298,461
-292,068
-203,540
Net income available to common shareholders
-471,650
-428,325
-298,461
-292,068
-203,540
Basic EPS
-
-1.45
-1.30
-2.20
-1.92
Diluted EPS
-
-1.45
-1.30
-2.35
-1.92
Basic average shares
-
294,774
229,823
132,732
106,150
Diluted average shares
-
294,774
229,823
140,514
106,150
EBITDA
-
-439,842
-279,392
-312,448
-147,096